A detailed history of Laurion Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 3,894,282 shares of BBIO stock, worth $93.9 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
3,894,282
Previous 4,388,873 11.27%
Holding current value
$93.9 Million
Previous $111 Million 10.81%
% of portfolio
1.36%
Previous 1.32%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.91 - $31.3 $11.8 Million - $15.5 Million
-494,591 Reduced 11.27%
3,894,282 $99.1 Million
Q2 2024

Aug 14, 2024

SELL
$23.0 - $31.04 $18.1 Million - $24.4 Million
-787,455 Reduced 15.21%
4,388,873 $111 Million
Q1 2024

May 15, 2024

SELL
$27.35 - $40.45 $1.79 Million - $2.65 Million
-65,505 Reduced 1.25%
5,176,328 $160 Million
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $11.8 Million - $21.6 Million
492,490 Added 10.37%
5,241,833 $212 Million
Q2 2023

Aug 14, 2023

BUY
$13.29 - $18.01 $16.4 Million - $22.3 Million
1,236,584 Added 35.2%
4,749,343 $81.7 Million
Q1 2023

May 15, 2023

BUY
$7.17 - $18.55 $9.25 Million - $23.9 Million
1,289,505 Added 58.0%
3,512,759 $58.2 Million
Q4 2022

Feb 14, 2023

BUY
$6.74 - $11.52 $1.34 Million - $2.29 Million
198,614 Added 9.81%
2,223,254 $16.9 Million
Q3 2022

Nov 14, 2022

BUY
$7.94 - $12.36 $4.37 Million - $6.8 Million
550,190 Added 37.31%
2,024,640 $20.1 Million
Q2 2022

Aug 15, 2022

BUY
$5.21 - $12.14 $4.06 Million - $9.45 Million
778,535 Added 111.87%
1,474,450 $13.4 Million
Q1 2022

May 16, 2022

BUY
$7.34 - $17.16 $5.11 Million - $11.9 Million
695,915 New
695,915 $7.06 Million
Q4 2019

Feb 13, 2020

SELL
$17.96 - $46.63 $201,152 - $522,256
-11,200 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$20.13 - $32.38 $277,794 - $446,844
-13,800 Reduced 55.2%
11,200 $240,000
Q2 2019

Aug 13, 2019

BUY
$26.97 - $27.55 $674,250 - $688,750
25,000 New
25,000 $674,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.57B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.